inarigivir

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug Nameinarigivir
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNucleotide-binding oligomerization domain-containing protein 2 antagonists +[2] 
TargetsRetinoic acid-inducible gene INucleotide-binding oligomerization domain-containing protein 2
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOrigenix Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrigenix Technologies Inc
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A